Schedule 13G ownership disclosure

BIO-TECHNE CORP COM

COMMON STOCK · CUSIP: 09073M104

Event date: 2025-09-30

Filing-level shares
3,350,818
Percent of class
2.2%
  • T. Rowe Price Associates, Inc.

    Shares: 3,350,818 · Class: 2.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-25-000801
Form type
SCHEDULE 13G/A
Filer
BIO-TECHNE Corp
CIK
CIK 842023
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub